More details at : www.Sebaclear.com
SebaClear Wipes- Salicylic Acid Supplement for Psoriasis & Seborrhea Relief!
May 20, 2013 by Leave a Comment
Newa Skin Rejuvenation Device – Two women discuss – Funny …
March 27, 2013 by Leave a Comment
Multisource radiofrequency for fractional skin resurfacing – significant reduction of wrinkles
March 27, 2013 by Leave a Comment
A recent study pergomed by a disguished Franch group fo Dermatologists perfomed a clinical study examining teh effciacy and safety ofr Multisource – EndyMed FSR fractiona skin resurfacing. The study included 10 subjects (Fitzpatrick ’ s skin type 2 – 3) with Fitzpatrick wrinkle and elastosis scale of 5 – 8 (average 7.3). Treatment was done with the Fractional skin resurfacing handpiece of the EndyMed PRO multisource radiofrequency system (EndyMed Ltd, Cesarea, Israel). Treatment was repeated each month up to a total of three treatment sessions. Patients photographs were graded according to accepted scales by a board certifi ed dermatologists. Patients ’ pain and satisfaction were scored using dedicated questionnaires. Doctors ’ satisfaction was also evaluated. Results : Post treatment skin erythema was noted in all treated patients, lasting up to 10 hours. Fifty six percent of patients reported no pain after treatment, and the rest (44%) reported minimal pain. All patients showed signifi cant reduction in the Fitzpatrick wrinkle score. Average Fitzpatrick wrinkle score was 7.3 at baseline, 4.9 at 1 month after the fi rst treatment, 4.2 at 1 month after the second treatment, and 4.1 at 1 month after the third treatment. The score was similar at 3 months after the third treatment with a score of 4.1. When asked at the end of three treatment sessions, all patients answered they will recommend the treatment to their friends (66% “ definitely yes ” and 33% “ yes ” ). When asked the same question 3 months after the end of treatment, all patients (100%) answered “ definitely yes ”.
Dahan S, Rousseaux I, Cartier H. Multisource radiofrequency for fractional skin resurfacing-significant reduction of wrinkles.
J Cosmet Laser Ther. 2013 Apr;15(2):91-7. Clinique St Jean Longuedoc , Toulouse , France.
New Clinical Study Confirms the Effectiveness of EndyMed Medical’s 3DEEP RF Technology in the Treatment of Facial Skin Laxity and Wrinkle Reduction on Asian Skin Types
March 27, 2013 by Leave a Comment
The March 2013 edition of the Journal of Cosmetics, Dermatological Sciences and Applications has published a study performed by Dr. Yohei Tanaka of the Clinica Tanaka Plastic, Reconstructive Surgery and Anti-Aging Center in Matsumoto, Japan on the effects of multisource RF treatments on Asian skin types, objectively evaluated for the first time with three-dimensional imaging.
Dr.Tanaka’s study involved 20 Japanese volunteers, 18 females and 2 males, aged 26 to 69 years. The RF device used in the study was the FDA cleared EndyMed PRO, a system that uses multiple phase-controlled RF generators. The twenty volunteers were treated on both cheeks, three treatment sessions with a 1 week interval between treatments.
By using 3D images as an objective measurement, the study found significant improvements in skin laxity. There was a significant reduction of facial volume measured in the treated areas 3 months after the end of the treatment sessions, which proves a long lasting skin tightening effect due to collagen remodeling. The study volunteers also reported a 95% satisfaction rate in the improvement of skin laxity, and a 90% satisfaction rate in the improvement of facial wrinkles.
Dr. Tanaka concluded that, in his view, the study proved the advantage of multisource RF treatments as a highly efficient, comfortable and low cost option for non invasive skin tightening. The data produced by the study shows that the EndyMed PRO’s phase-controlled, multisource RF technology provides safe and effective treatment of facial skin laxity and wrinkle reduction in Asian patients.
One of the highlights of Dr. Tanaka’s study is his use of 3D imaging with quantitative volume measurements to objectively assess the study’s results. The 3D system is designed to accurately capture the surface shape, and indicates the volume changes between pre-treatment and post-treatment images in the face. By showing the varying degrees of skin tightening achieved in colors ranging from yellow to red, Dr. Tanaka’s use of 3D imaging provided a unique insight into the depth and effectiveness of RF deep volumetric heating on treating skin laxity.
Non-invasive skin tightening procedures are increasingly on demand today, and radiofrequency technology is considered one of the best treatment options available. Most RF systems today use one (Monopolar) or two (bipolar) RF generators that allow relatively superficial or painful non-ablative treatments. EndyMed Medical developed a new, unique FDA cleared RF technology called 3DEEP, which uses, for the first time, multiple phase controlled RF generators that direct RF energy deep into the dermis for optimal, painless collagen remodeling.
The thermal effect of collagen remodeling reduces the appearance of wrinkles and laxity, and improves contours on both the face and body. Instead of one or two RF generator as used in competing systems, EndyMed’s 3DEEP technology consists of an array of multiple RF generators and a sophisticated algorithm to manage the phase of the energy flowing between sets of contact electrodes. The repelling forces between adjacent electromagnetic fields drive the energy vertically into the target tissue, reducing significantly the energy flowing along the skin’s surface and eliminating the need for skin cooling.
The full article can be found on:
http://www.scirp.org/journal/PaperDownload.aspx?paperID=28582
For more information, please see http://www.endymed.com.
Breakthrough Dermatological Solution for Seborrheic Dermatitis (Without Steroids)
December 21, 2012 by Leave a Comment
Redness and scales on along the peri-nasal skin folds, between the eyebrows and on the border of the scalp are a common disorder affecting 3-5% of the population.
This hard to treat disorder may appear at any age but is more common between the ages
of 30 to 50 years. These symptoms, referred as seborrhea or seborrheic dermatitis are more prevalent in periods of stress and present a significant aesthetic disorder.
Basic science research have shown that a fungus (malassezia, Pityrosporum)
has a role in the pathogenesis of the disorder causing a trigger
to inflammation in prone areas. Topical solutions containing corticosteroids offer short time relief but have multiple side effects when used for prolonged periods of time.
Medical evaluation of the results showed moderate improvement in 93.75 % of patients after 2 weeks of treatment and in 100% of patients after 4 weeks of treatment. Patient self-assessment showed that 80% of patients were satisfied with redness reduction, 90% of patients were satisfied with skin scale reduction, 80% of Patients were satisfied with skin oiliness reduction and 90% of the patients were satisfied with the reduction in skin roughness and scale.
SebaCare100 mode of action::
[1] Proven antifungal activity (pityrosporum orbiculare).
[2] Anti inflammatory activity.
[3] Keratholytic activity (removal of scale).
[4] Enhancement of skin barrier.
Clinical results:
Sebacare100 Significant improvement of Seborrheic Dermatitis
Where to buy ??
For US customers:
For out of US Customers:
For Israeli customers:
Download full product brochure at:
Sebacare100 brochure (English)
Full Clinical Study details:
SebaCare100 Dermatological Clinical Study
Share on Facebook
Professional high end Radio-frequency Skin Tightening Technology customized for Home Use.
November 23, 2012 by Leave a Comment
The Newa™ Skin Rejuvenation System uses 3DEEP® radiofrequency (RF) technology, which has been proved safe and effective in tens of thousands of professional treatments worldwide. 3DEEP technology has been the subject of multiple peer reviewed clinical studies published in top medical journals.
Through clinical studies, the Newa system has been proven effective in reducing the appearance of fine lines and wrinkles. Clinical evaluat
ion has shown improvement in skin texture, skin tightening and reduction in the appearance of wrinkles in most users. Most users noticed an immediate improvement in the appearance and texture of their skin right after their first treatment. Long-term and long-lasting improvement started at the end of the first month of treatments and reached its maximum improvement 3 months later.
- Sixty patients completed the study, with follow up after one month and again after 3 months.
- More than 6000 photographs were taken, documenting the improvements.
- Three independent dermatologists who were not involved in the clinical study reviewed and assessed the results. They found proven, visible reduction of wrinkles in 95 % of users.
For more details:
Share on FacebookBlue Light Acne Phototherapy Scientific Research
July 10, 2012 by Leave a Comment
J Dermatol Sci. 2002 Nov;30(2):129-35.
Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation.
Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T.
Source
Department of Dermatology, Kinki University School of Medicine, Ohno-Higashi 377-2, Osaka-Sayama city, Osaka 589-8511, Japan. kawada@med.kindai.ac.jp
Abstract
The purpose of this study was to investigate the efficacy of phototherapy with a newly-developed high-intensity, enhanced, narrow-band, blue light source in patients with mild to moderate acne. An open study was performed in acne patients who were treated twice a week up to 5 weeks. Acne lesions were reduced by 64%. Two patients experienced dryness. No patient discontinued treatment due to adverse effects. In vitro investigation revealed that irradiation from this light source reduced the number of Propionibacterium acnes (P. acnes), but not Staphylococcus epidermidis that were isolated from the acne patients. Phototherapy using this blue light source was effective and well tolerated in acne patients and had an ability to decrease numbers of P. acnes in vitro, suggesting that this phototherapy may be a new modality for the treatment of acne.
J Cosmet Dermatol. 2008 Sep;7(3):180-8.
An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris.
Ammad S, Gonzales M, Edwards C, Finlay AY, Mills C.
Source
Cardiff University, Cardiff, UK. s_ammad@yahoo.com
Abstract
BACKGROUND:
Acne vulgaris is a common skin condition that affects 8 out of 10 people. It varies from mild to severe, and different treatments target various aspects of the disease. Propionibacterium acnes, one of the culprits involved in the pathogenesis of acne vulgaris, is the main target of all major medical treatments used. Studies conducted in recent years have shown favorable effects within the visible light spectrum for the treatment of acne vulgaris.
OBJECTIVE:
In this study, we have evaluated the use of intense blue light within the spectral range of 415-425 nm (peak 420 nm) in the treatment of acne vulgaris.
METHODS:
Twenty-one patients with mild to moderate facial acne were treated with blue light phototherapy. All patients were given 14-min treatment sessions twice a week for 4 weeks. Acne severity was assessed using the Leeds Technique for grading and lesion counts. Disability was assessed using the Dermatology Life Quality Index (DLQI). In addition, standard digital and cross-polarized light photographs were taken and graded by a blinded evaluator. Visual analog scale (VAS) scores and cultures for P. acnes were carried out before starting the treatment and upon completion of the treatment.
RESULTS:
Significant improvement was achieved in the Leeds Acne Grade (P = 0.001). The inflammatory (P = 0.001) and noninflammatory (P = 0.06) lesion counts also improved significantly. A similar change was noted in the DLQI (P = 0.001); a degree of significance was also achieved in the patients’ and the investigators’ VAS scores (P = 0.01 and P = 0.001, respectively). P. acnes colony counts failed to show a significant decrease at the end of the treatment and remained almost constant (P = 0.660).
CONCLUSIONS:
We believe that blue light does appear to have some role in the management of acne and may be beneficial for the treatment of a select group of mild to moderate acne patients.
J Cosmet Laser Ther. 2003 Jun;5(2):111-7.
The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420 nm light source.
Source
Beit Harofim Holon, Israel.
Abstract
BACKGROUND:
Available topical treatments are slow and frequently irritating. Oral therapies may be associated with increased bacterial resistance (antibiotics) or possible severe side effects (oral isotretinoin). In vitro and in vivo exposure of acne bacteria to 405-420 nm ultraviolet (UV) free blue light results in the photo-destruction of these bacteria through the effects on the porphyrins produced naturally by Propionibacterium acnes. A novel, high-intensity, narrow band 420 nm UV free blue light has been shown to decrease inflammatory acne lesions after eight bi-weekly treatments.
OBJECTIVES:
To examine the effects of high-intensity, narrow band 420 nm UV free blue light (ClearLight) on inflammatory acne lesions.
METHODS:
Three studies were carried out to examine the clinical effects of high-intensity, narrow band blue light on papulo-pustular acne: the split-face dose-response study, the full-face open trial and the split-face, double-blind controlled study. The studies enrolled 10, 13 and 23 patients respectively.
RESULTS:
The data show more than an 80% response to 420 nm acne phototherapy with a significant reduction of 59-67% of inflammatory acne lesions after only eight treatments of 8-15 minutes. The reduction in lesions was steady in the follow-ups at 2, 4 and 8 weeks after the end of therapy. Prolonged remission was evident in the 8 weeks after the end of therapy. No adverse effects or patient discomfort were noted in any of the patients.
CONCLUSIONS:
Acne phototherapy by high intensity, narrow band 405-420 nm light is proven to be an attractive, fast, effective, non-invasive alternative to current topical and parenteral anti-acne remedies.
Share on FacebookBreakthrough Scientific research proves the efficacy of the non steroidal Sebacare100 for treatment in facial and scalp seborrhea
July 5, 2012 by 2 Comments
Many men and women suffer from red and oily skin, in various skin areas, especially between the eyebrows, sides of the nose and the edge of the forehead and scalp. The causes of this common condition, called Seborrhea, include an inherited predisposition, a plurality of pityrosporum ovale skin fungus, local inflammation and the thickening layer of skin scale. The situation described above can be relieved by using medications containing steroids. Although these medications may bring temporary relief, long-term use involves multiple side effects.
Objectives: This clinical study was designed to examine the SebaCare100product for red oily skin relief. The product is a clear non steroidal liquid containing non medical natural ingredients, including tea tree oil, chamomile, and salicylic acid.
Methods: The study was performed by Prof. Avner Shemer from the Department of Dermatology , Sheeba Medical Center, and the Sackler Medical School, Tel Aviv University in Israel. After IRB approval, the product has been tested on 25 patients – 16 years old and above volunteers with red and oily skin in two of the following areas: Sides of the nose, between the eyebrows, forehead hair margin, scalp skin. The participants did not have any local or another systemic treatment and agreed to be part of the experiment. Patients suffering from another skin disease or with known allergy to any of the product’s ingredients as well as pregnant or nursing women did not participate in the experiment. The treatment lasted a month during which patients sprayed a little of the product on top of their fingers twice a day, spreading the material over the infected area. In the second month of the experiment, patients continued to use the product twice a week. The volunteers were examined and photographed before treatment, during the second, fourth and eight week of starting treatment. During each treatment session participants were examined and completed a questionnaire assessing treatment efficacy.
Lab experiment: Pityrosporum ovale mycological Cultures (the fungus involved in the pathophysiology of Seborrheic dermatitis) were prepared In laboratory conditions. Various concentrations of Sebacare100 solution were added. Qualitative and quantitative examination proved a significant reduction in number of spores in cultures in which the product was added. Clinical response to treatment was classified according to four levels. 0 = No response 1 – = slight improvement 2 = moderate improvement 3 = an excellent improvement to complete healing.
What were the results of the Study ?
Medical evaluation of the results showed moderate improvement in 93.75 % of patients after 2 weeks of treatment and in 100% of patients after 4 weeks of treatment. Patient self-assessment showed that 80% of patients were satisfied with redness reduction, 90% of patients were satisfied with skin scale reduction, 80% of Patients were satisfied with skin oiliness reduction and 90% of the patients were satisfied with the reduction in skin roughness and scale.
Were side effects involved?
Out of 25 patients recruited for the experiment 22 completed the experiment. Three patients did not complete the experiment due to personal reasons that are independent of the experiment. 20% of patients reported a tingling sensation after product use. The tingling subsided after a few days of product use. Allergy or other side effects were not observed during the experiment.
Summary of results: Researchers have found that SebaCare100 is quite effective in relieving redness, scale and oiliness of the skin in patients suffering from facial and scalp seborrhea. The product is safe for use without remarkable side effects.
Where to buy ??
For US customers:
www.Sebaclear.com
For out of US Customers:
For Israeli customers:
Share on Facebook
No Acne – The Dermatologist way to clear skin – FREE E-BOOK July 2012
July 5, 2012 by Leave a Comment
